Title:
Glucagon analog
Document Type and Number:
Japanese Patent JP6023048
Kind Code:
B2
Abstract:
The invention provides materials and methods for promoting weight loss or preventing weight gain and for treating diabetes and associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptide compounds effective in such methods. The compounds may mediate their effect by having, for example, increased selectivity for the GLP-1 receptor compared to human glucagon.
Inventors:
Ditter River
Eddie Mayer
Eddie Mayer
Application Number:
JP2013515699A
Publication Date:
November 09, 2016
Filing Date:
June 24, 2011
Export Citation:
Assignee:
Zealand Pharma Actiesl Scab
International Classes:
C07K14/605; A61K31/155; A61K31/455; A61K31/517; A61K38/26; A61K38/28; A61K45/00; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/10; A61P9/12; A61P43/00
Domestic Patent References:
| JP2012532898A |
Foreign References:
| WO2010070251A1 | ||||
| WO2011088837A1 | ||||
| WO2008152403A1 |
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei